Mitotherapy as a novel therapeutic strategy for mitochondrial diseases.
Mitochondria are multi-functional organelles in mammalian cells that mainly supply energy and maintain cellular homeostasis. Over 100 human diseases are known to be attributed to mitochondrial dysfunction. Mitochondrial therapy (mitotherapy) is to transfer functional exogenous mitochondria into mitochondria-defective cells for recovery of the cell viability and consequently prevention of the disease progress. Accumulating evidence has indicated that exogenous mitochondria can directly enter mammalian cells and be transplanted rapidly to animal tissue cells for disease therapy following local and intravenous administration. Current studies also suggest that mitochondrial transfer between cells through nanotubes or microvesicles is a new mode of cell survival when normal cells donate their mitochondria to damaged cells, which raises the possibility of manipulating cell growth and proliferation through promotion or blockage of the mitochondrial migration. The transferred mitochondria play their roles in recipient cells, including energy production and maintenance cell function. Thus, mitotherapy makes the possibility of modulation cell survival and would be a potential therapeutic strategy for mitochondrial diseases.